• Je něco špatně v tomto záznamu ?

Structure-activity study of new inhibitors of human betaine-homocysteine S-methyltransferase

V. Vaněk, M. Buděšínský, P. Kabeleová, M. Šanda, M. Kožíšek, I. Hančlová, J. Mládková, J. Brynda, I. Rosenberg, M. Koutmos, T.A. Garrow, J. Jiráček

. 2009 ; 52 (12) : 3652-3665.

Jazyk angličtina Země Spojené státy americké

Typ dokumentu práce podpořená grantem, Research Support, N.I.H., Extramural

Perzistentní odkaz   https://www.medvik.cz/link/bmc11016859

Betaine-homocysteine S-methyltransferase (BHMT) catalyzes the transfer of a methyl group from betaine to l-homocysteine, yielding dimethylglycine and l-methionine. In this study, we prepared a new series of BHMT inhibitors. The inhibitors were designed to mimic the hypothetical transition state of BHMT substrates and consisted of analogues with NH, N(CH(3)), or N(CH(3))(2) groups separated from the homocysteine sulfur atom by a methylene, ethylene, or a propylene spacer. Only the inhibitor with the N(CH(3)) moiety and ethylene spacer gave moderate inhibition. This result led us to prepare two inhibitors lacking a nitrogen atom in the S-linked alkyl chain: (RS,RS)-5-(3-amino-3-carboxypropylthio)-3-methylpentanoic acid and (RS)-5-(3-amino-3-carboxypropylthio)-3,3-dimethylpentanoic acid. Both of these compounds were highly potent inhibitors of BHMT. The finding that BHMT does not tolerate a true betaine mimic within these inhibitors, especially the nitrogen atom, is surprising and evokes questions about putative conformational changes of BHMT upon the binding of the substrates/products and inhibitors.

000      
03229naa 2200529 a 4500
001      
bmc11016859
003      
CZ-PrNML
005      
20121113101644.0
008      
110628s2009 xxu e eng||
009      
AR
040    __
$a ABA008 $b cze $c ABA008 $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Vaněk, Václav. $7 _AN044668
245    10
$a Structure-activity study of new inhibitors of human betaine-homocysteine S-methyltransferase / $c V. Vaněk, M. Buděšínský, P. Kabeleová, M. Šanda, M. Kožíšek, I. Hančlová, J. Mládková, J. Brynda, I. Rosenberg, M. Koutmos, T.A. Garrow, J. Jiráček
314    __
$a Institute of Organic Chemistry and Biochemistry, Academy of Sciences of the Czech Republic, v.v.i., Flemingovo nam. 2, 166 10 Prague 6, Czech Republic.
520    9_
$a Betaine-homocysteine S-methyltransferase (BHMT) catalyzes the transfer of a methyl group from betaine to l-homocysteine, yielding dimethylglycine and l-methionine. In this study, we prepared a new series of BHMT inhibitors. The inhibitors were designed to mimic the hypothetical transition state of BHMT substrates and consisted of analogues with NH, N(CH(3)), or N(CH(3))(2) groups separated from the homocysteine sulfur atom by a methylene, ethylene, or a propylene spacer. Only the inhibitor with the N(CH(3)) moiety and ethylene spacer gave moderate inhibition. This result led us to prepare two inhibitors lacking a nitrogen atom in the S-linked alkyl chain: (RS,RS)-5-(3-amino-3-carboxypropylthio)-3-methylpentanoic acid and (RS)-5-(3-amino-3-carboxypropylthio)-3,3-dimethylpentanoic acid. Both of these compounds were highly potent inhibitors of BHMT. The finding that BHMT does not tolerate a true betaine mimic within these inhibitors, especially the nitrogen atom, is surprising and evokes questions about putative conformational changes of BHMT upon the binding of the substrates/products and inhibitors.
590    __
$a bohemika - dle Pubmed
650    _2
$a betain-homocystein-S-methyltransferasa $x antagonisté a inhibitory $7 D050940
650    _2
$a racionální návrh léčiv $7 D015195
650    _2
$a inhibitory enzymů $x farmakologie $x chemická syntéza $x chemie $7 D004791
650    _2
$a homocystein $x analogy a deriváty $x farmakologie $x chemická syntéza $x chemie $7 D006710
650    _2
$a lidé $7 D006801
650    _2
$a molekulární struktura $7 D015394
650    _2
$a kyseliny pentanové $x farmakologie $x chemická syntéza $x chemie $7 D010421
650    _2
$a stereoizomerie $7 D013237
650    _2
$a vztahy mezi strukturou a aktivitou $7 D013329
655    _2
$a práce podpořená grantem $7 D013485
655    _2
$a Research Support, N.I.H., Extramural $7 D052061
700    1_
$a Buděšínský, Miloš, $d 1944- $7 jn20010309100
700    1_
$a Kabeleová, Petra $7 xx0110456
700    1_
$a Šanda, Miloslav. $7 xx0210970
700    1_
$a Kožíšek, Milan $7 xx0100179
700    1_
$a Hančlová, Ivona $7 xx0106064
700    1_
$a Mládková, Jana. $7 _AN059447
700    1_
$a Brynda, Jiří $7 xx0100180
700    1_
$a Rosenberg, Ivan, $d 1948- $7 xx0086095
700    1_
$a Koutmos, Markos
700    1_
$a Garrow, Timothy A.
700    1_
$a Jiráček, Jiří, $d 1965- $7 xx0098873
773    0_
$t Journal of Medicinal Chemistry $w MED00010049 $g Roč. 52, č. 12 (2009), s. 3652-3665
910    __
$a ABA008 $b x $y 2
990    __
$a 20110720122333 $b ABA008
991    __
$a 20121113101659 $b ABA008
999    __
$a ok $b bmc $g 864099 $s 726651
BAS    __
$a 3
BMC    __
$a 2009 $x MED00010049 $b 52 $c 12 $d 3652-3665 $m Journal of medicinal chemistry $n J Med Chem
LZP    __
$a 2011-3B09/BBjvme

Najít záznam